Utilising JAK Inhibitors in Identifying Areas of Unmet Needs that have the Potential to be Served
Time: 9:00 am
day: Pre-Conference Workshop Day
Details:
- Exploring Aclaris’ current success of JAKi in Atopic Dermatitis
- Identifying the sub populations of patients within treated diseases that either are not well served and explore whether inhibition poses therapeutic possibilities
- Looking forward what are the next therapeutic opportunities with JAK
